Headlines
Bloomberg MarketsKalshi Approved for Margin Trading as It Lures Wall Street ProsBloomberg MarketsOracle’s Credit Risk Measure Nears Record High on AI-Debt FearsBloomberg MarketsMerz Signals Germany to Take Stake in Franco-German Tank MakerBloomberg MarketsTrump to Sign Order to Get TSA Staff PaidBloomberg MarketsIran War Triggers Economic Uncertainty, Credit Concerns Persist | Real Yield 3/27/2025Financial TimesOil hits $112 as Trump deadline extension fails to calm marketsBloomberg MarketsRussia Set to Ban Gasoline Exports From April 1 as Prices JumpBloomberg MarketsNasdaq Correction Exposes AI Divide | Open Interest 3/27/2026Financial TimesGoogle nears deal to help finance multibillion-dollar data centre leased to AnthropicFinancial TimesStocks and bonds slump in tandem as Iran shock leaves investors ‘nowhere to hide’Bloomberg MarketsGoldman Traders Warn Against Shorting Stocks Amid ‘Upside’ RiskBloomberg MarketsTotal Inks Deal to Use EDF’s Nuclear Power for French RefineriesEconbrowser“Geopolitics becoming ‘key risk’ for central banks – panel”Bloomberg MarketsThe Potential for Real MiseryBloomberg MarketsUS Finalizes Higher Biofuels Quota to Boost Domestic DemandBloomberg MarketsKalshi Approved for Margin Trading as It Lures Wall Street ProsBloomberg MarketsOracle’s Credit Risk Measure Nears Record High on AI-Debt FearsBloomberg MarketsMerz Signals Germany to Take Stake in Franco-German Tank MakerBloomberg MarketsTrump to Sign Order to Get TSA Staff PaidBloomberg MarketsIran War Triggers Economic Uncertainty, Credit Concerns Persist | Real Yield 3/27/2025Financial TimesOil hits $112 as Trump deadline extension fails to calm marketsBloomberg MarketsRussia Set to Ban Gasoline Exports From April 1 as Prices JumpBloomberg MarketsNasdaq Correction Exposes AI Divide | Open Interest 3/27/2026Financial TimesGoogle nears deal to help finance multibillion-dollar data centre leased to AnthropicFinancial TimesStocks and bonds slump in tandem as Iran shock leaves investors ‘nowhere to hide’Bloomberg MarketsGoldman Traders Warn Against Shorting Stocks Amid ‘Upside’ RiskBloomberg MarketsTotal Inks Deal to Use EDF’s Nuclear Power for French RefineriesEconbrowser“Geopolitics becoming ‘key risk’ for central banks – panel”Bloomberg MarketsThe Potential for Real MiseryBloomberg MarketsUS Finalizes Higher Biofuels Quota to Boost Domestic Demand
Home/CNBC Top News
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
CNBC Top Newsmarkets

Every Cure’s drug repurposing strategy isn't what you think, and it could change rare disease treatment

CNBC Top News
Friday, March 27, 2026 at 5:02 PM
~4 min read

Original Report

When David Fajgenbaum and his colleagues launched the drug repurposing non-profit Every Cure, they chose a path that challenged the traditional research model.

Glass House Analysis

This story reflects the interconnected nature of modern economic systems, where developments in one sector inevitably affect others. Understanding these connections is essential for grasping how policy decisions and market movements translate into real-world outcomes for families, workers, and communities. The economy is not an abstract system of numbers—it's the sum total of decisions about who works, who prospers, and who struggles.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%